Cargando…

Assessment of the Isoniazid Preventive Therapy Uptake and Associated Characteristics: A Cross-Sectional Study

OBJECTIVE: To assess the uptake of isoniazid preventive therapy (IPT) by eligible children in Kigali, Rwanda, and associated individual, households, and healthcare systems characteristics. METHODS: A cross-sectional study was conducted among child contacts of index cases having sputum smear-positive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birungi, Francine Mwayuma, Graham, Stephen, Uwimana, Jeannine, van Wyk, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960530/ https://www.ncbi.nlm.nih.gov/pubmed/29854455 http://dx.doi.org/10.1155/2018/8690714

Ejemplares similares

Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study
por: Birungi, Francine Mwayuma, et al.
Publicado: (2019)

Xpert MTB/RIF assay did not improve diagnosis of pulmonary tuberculosis among child contacts in Rwanda
por: Birungi, Francine Mwayuma, et al.
Publicado: (2018)

Pellagra in isoniazid preventive and antiretroviral therapy
por: Kipsang, John Koech, et al.
Publicado: (2019)

Hyperglycaemia induced by isoniazid preventive therapy
por: Ganguly, Roshni Jhan, et al.
Publicado: (2018)

Isoniazid Preventive Therapy for Tuberculosis in People Living with HIV: A Cross Sectional Study in Butebo, Uganda
por: Oonyu, Lawrence, et al.
Publicado: (2022)

Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point
por: Tadesse, Yared, et al.
Publicado: (2016)

Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe
por: Nyathi, Saziso, et al.
Publicado: (2019)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Operational challenges in managing Isoniazid Preventive Therapy in child contacts: A high-burden setting perspective
por: van Wyk, Susan S, et al.
Publicado: (2011)

Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania
por: Nyarubamba, Renatus Fabiano, et al.
Publicado: (2022)

Implementation of isoniazid preventive therapy in southern Lima, Peru: an analysis of health center characteristics
por: Zegarra-Chapoñan, Roberto, et al.
Publicado: (2021)

Isoniazid Preventative Therapy uptake for child household contacts of tuberculosis index cases, Kisumu County, Kenya, 2014-2015
por: Burmen, Barbara, et al.
Publicado: (2019)

Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa
por: Adeniyi, Oladele Vincent, et al.
Publicado: (2019)

Eligibility for Isoniazid Preventive Therapy in South African Gold Mines
por: Lewis, James J., et al.
Publicado: (2013)

A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia
por: Datiko, D. G., et al.
Publicado: (2017)

Implementation of Isoniazid Preventive Therapy Among HIV-Infected Children at Health Facilities in Nairobi County, Kenya: A Cross-Sectional Study
por: Mwangi, Peninah M, et al.
Publicado: (2019)

Low prevalence of isoniazid preventive therapy uptake among HIV-infected patients attending tertiary health facility in Lagos, Southwest Nigeria
por: Busari, Abdulwasiu Adeniyi, et al.
Publicado: (2021)

Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews
por: Adams, Lisa V, et al.
Publicado: (2014)

Implementing an isoniazid preventive therapy program for people living with HIV in Thailand
por: Danyuttapolchai, Junya, et al.
Publicado: (2017)

Drug-related pellagra in a Ugandan woman on isoniazid preventative therapy
por: Coates, Sarah J., et al.
Publicado: (2020)

Assessment of isoniazid preventive therapy in the reduction of tuberculosis among ART patients in Arba Minch Hospital, Ethiopia
por: Abossie, Ashenafi, et al.
Publicado: (2017)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

An evaluation of the isoniazid preventive therapy program performance for under-fives in Kwekwe City, January 2019 - December 2020: a descriptive cross-sectional study
por: Makova, Nyashadzashe Cosmas, et al.
Publicado: (2022)

Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation
por: Rutherford, Merrin E, et al.
Publicado: (2012)

Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia
por: Wesen, Amenu, et al.
Publicado: (2012)

Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis
por: Ayieko, James, et al.
Publicado: (2014)

Serious hepatotoxicity following use of isoniazid preventive therapy in HIV patients in Eritrea
por: Russom, Mulugeta, et al.
Publicado: (2018)

Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania
por: Hunter, Olivia F., et al.
Publicado: (2020)

Implementation of isoniazid preventive therapy in people living with HIV in Zambia: challenges and lessons
por: Kagujje, Mary, et al.
Publicado: (2019)

Assessment of Isoniazid Preventive Therapy Outcome Among People Living with HIV in a Referral Hospital, Northeast Ethiopia
por: Mengesha, Yohannes, et al.
Publicado: (2020)

A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial
por: Kakande, Elijah, et al.
Publicado: (2022)

Isoniazid-induced subacute cutaneous lupus erythematosus in an HIV-positive woman: a rare side effect to be aware of with the current expansion of isoniazid preventive therapy
por: Luwanda, Lameck Bonaventure, et al.
Publicado: (2018)

Correction to: Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania
por: Hunter, Olivia F., et al.
Publicado: (2020)

Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV
por: Kay, Alexander W., et al.
Publicado: (2020)

Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis
por: Kendall, Emily A., et al.
Publicado: (2021)

Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia
por: Winardi, Wira, et al.
Publicado: (2022)

Agreement Between Measures of Adherence to Isoniazid Preventive Therapy Among People With HIV in Uganda
por: Forman, Leah S, et al.
Publicado: (2022)

Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use
por: Hahn, Judith A., et al.
Publicado: (2023)

Isoniazid and alopecia
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
por: Fernández-Guerrero, Manuel L., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_4lj0u09m8h5for67l2nhllf8gn